Back to Trials
NCT06921902RecruitingAccepts Healthy Volunteers

Glycemic Metrics and Patterns in People With and Without Prediabetes

Abbott Diabetes Care

Start Date

2/28/2025

Completion Date

12/1/2026

Summary

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Detailed Description

This is a non-pivotal, non-randomized, multi-center, prospective, non-significant risk to evaluate the glycemic profiles of people with and without a prediabetes diagnosis using continuous glucose monitoring. Up to 2000 subjects will be enrolled in up to 20 sites. Approximately 50% of evaluable subjects will have a prediabetes diagnosis.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Subject must be at least 18 years of age. * Subject must be willing and able to provide written signed and dated informed consent. Exclusion Criteria: * Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes. * Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment. * Subject is known to be pregnant at the time of enrollment. * Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin. * Subject is currently on any form of treatment indicated for the treatment of diabetes. * Subject is currently on any form of medication indicated for weight loss.

Interventions

DEVICE

FreeStyle Libre 3

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pre Diabetes

Locations

Diabetes and Obesity Care

Bend, Oregon 97702

United States